UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004227
Receipt No. R000005081
Scientific Title Phase II study of erlotinib as third-line monotherapy in patients with advanced non-small cell lung cancer
Date of disclosure of the study information 2010/09/17
Last modified on 2011/03/17 13:08:02

No. Disposal Last modified on Item of update
1 Insert 2010/09/17 09:37:13
2 Update 2010/09/27 13:13:50 Interventions/Control_1
Interventions/Control_1
3 Update 2011/03/17 13:08:02 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded


Contact us.